ICG's pharma digital marketing practice covers HCP digital engagement, e-detailing, CLM content, brand websites, pharma SEO, programmatic for HCP audiences, and content marketing — for prescription, OTC, and biologics brands operating under OPPI and Drug & Magic Remedies Act constraints. Built by IIT BHU pharmaceutical engineers who understand what an HCP needs to hear digitally — and what a regulator will object to.
Your digital agency built a Facebook campaign. Medical review pulled half the claims. The other half went live — to consumers, not HCPs.
This is the gap. Generalist digital agencies don't understand pharma's audience structure (HCP-first, not consumer-first), claim limitations (every promotional statement maps to a citation), or channel choice (LinkedIn + closed HCP communities + CME platforms — not Meta Ads). ICG's pharma digital practice is built around the HCP audience, the regulatory environment, and the science that makes a brand differentiated. The digital strategy follows the medical story.
LinkedIn HCP targeting, closed HCP communities, CME platform sponsorship, programmatic on HCP-only sites. Compliance-safe creative.
Closed Loop Marketing modules for iPad-based detailing. Remote e-detailing for digital HCP visits. Built for 3-minute attention.
HCP-gated brand sites with login, MLR-approved content, prescription-only access gating. Regulatorially audit-ready by design.
Therapy-area SEO that targets HCP search intent. Mechanism-aware content. Indian medical search behaviour modelled in keyword strategy.
Disease-state awareness content, HCP education modules, MSL support materials. Evidence-grounded. Citation-mapped. Field-force-deployable.
Connect digital touchpoints to prescription outcomes via Pharos RxFlow. Most agencies cannot do this. ICG built the tool for exactly this measurement.
ICG's Co-Founding Team and pharma practice lead are pharmaceutical engineers from IIT BHU's Department of Pharmaceutical Engineering and Technology — B.Tech and M.Tech graduates who have studied drug metabolism, formulation science, pharmacokinetics, and clinical pharmacology.
This is not a credential for a website. It is the reason why ICG manuscripts have fewer scientific errors in medical review, why ICG PSURs have fewer clarification cycles, and why the scoping call for a literature monitoring engagement sounds different from every other agency you've briefed. The science is understood before the brief is written.
ICG's commercial and field force engagements run on RxFlow, RouteIQ, Gate, Signal, and Pulse — five tools that connect field activity to prescription outcomes.
Explore the full Pharos platform →AI Scientific Writing
AI-guided manuscript development from topic selection to submission-ready output. Journal fit intelligence. CONSORT/PRISMA embedded from Day 1.
Literature Monitoring
Adverse-event-driven literature surveillance. Validated PubMed queries. De-duplication. Evidence scoring. Audit-ready search logs.
PV Resource Allocation
Risk-based drug tiering and defensible PV staffing. Objective tier from signal frequency and seriousness. Headcount you can defend with data.
Drug AE Intelligence
Single-drug adverse event visualization dashboard. On-demand data refresh. Spot signals before they escalate.
Prescription Intelligence
HCP-level prescription intelligence. Visit history, AI call analysis. See Rx switching risk before it moves.
Explore RxFlow →MR Route Optimization
AI route planning for medical representatives. Priority-scored daily call plans. Right HCP, right day, every day.
Explore RouteIQ →Sales Pipeline Intelligence
Stagnation alerts before deals go cold. Stage bottleneck heatmaps. Intervene before it's too late.
Explore Gate →MR AI Coaching
AI coaching after every HCP visit. Post-visit feedback, objection analysis. Turn each visit into a prescription.
Explore Signal →Pharma MIS Command Centre
360° commercial intelligence for leadership. Revenue, field force, distributor, market — one real-time view.
Explore Pulse →Every ICG pharma engagement runs on some combination of these nine modules. The pilot engagement determines which ones are active from Day 1.
Start a pilot project →Every ICG pharma engagement is led personally by Aditi Tripathi — M.Pharm, IIT BHU — with Abhash, Deep and Rohit (Co-Founding Team) bringing the scientific rigour, delivery architecture and commercial lens built across 8+ years. IIT BHU pharmaceutical engineers at every level of the engagement.
60+ specialists. One process. Every deliverable in-house. Gurgaon, since 2018.
Strategy Lead · IIT BHU + IIM Bangalore
Leads scientific strategy and quality governance. Sets the standard for scientific rigour across every engagement.
Profile →
Operations Lead · IIT BHU (B.Tech + M.Tech)
Owns the AI-powered delivery system — the multi-tenant operations layer that runs every pharma engagement on time and on spec.
Profile →
Business & Growth Lead · IIT BHU + IIM Rohtak
Pharma engineer who owns business growth and the commercial lens connecting science to prescription outcomes.
Profile →
IIT BHU · M.Pharm
Aditi leads every pharma engagement end to end — from scoping the scientific writing architecture to governing quality across delivery. Her M.Pharm from IIT BHU means she doesn't need the science explained to her. "She explains it to everyone else."
One deliverable. Full ICG process. Audit trail. Then you decide.
A founder will reach out within one business day. In the meantime — WhatsApp Rohit directly for the fastest reply.
💬 Message Rohit on WhatsApp
For pharma / life sciences — medical writing, scientific communications, regulatory support — I reply personally.
Message Rohit on WhatsAppOr call: +91 81302 26224